NEW METHODS FOR THE SYNTHESIS OF PHORBOXAZOLE
佛罗唑唑的合成新方法
基本信息
- 批准号:2859180
- 负责人:
- 金额:$ 18.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-04 至 2001-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Phorboxazole A is an interesting new natural product that shows
remarkable anticancer activity. In tests against the NCI's panel tumor
cell lines it was found, for example, to inhibit the growth of colon
tumor cells HCT-116 with a GI50 of 4.36 X 10-10 M. Such exceptional
potency against human solid tumors is comparable with the most potent
agents known to date, and makes the synthesis of phorboxazole A a high
priority in the development of new anticancer agents. Phorboxazole A and
B were isolated from a marine sponge, Phorbos sp. in 0.040 percent and
0.017 percent of the dry weight, which provided enough material for
structure determination and initial biological evaluation, but will not
support extensive anticancer evaluation or the preparation of structural
analogs. Further progress in the evaluation of phorboxazole A and its
analogs for cancer chemotherapy will depend upon the development of
effective routes for its total synthesis.
We propose a highly convergent synthesis of phorboxazole using our newly
discovered reductive acetylation and Prins cyclization of an ester to
give a tetrahydropyran stereoselectively. The scope of this reaction
will be investigated, and two of the tetrahydropyran rings in the
phorboxazoles will be prepared using this method. The side chain A and
macrocycle B will be coupled using a sulfone alkylation reaction
inspired by Ley's work. Syntheses of the individual optically pure
fragments are based on reliable and established methods. The overall
synthetic route is convergent and is well suited for the preparation of
analogs.
甲磷唑是一种有趣的天然产物
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT D. RYCHNOVSKY其他文献
SCOTT D. RYCHNOVSKY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT D. RYCHNOVSKY', 18)}}的其他基金
ACQUISITION OF A 500 MHZ NMR SPECTROMETER: CHEMISTRY
获取 500 MHZ 核磁共振波谱仪:化学
- 批准号:
6973228 - 财政年份:2004
- 资助金额:
$ 18.15万 - 项目类别:
Synthesis of Anticancer Agents Using Prins Cyclizations
使用 Prins 环化合成抗癌剂
- 批准号:
6522261 - 财政年份:2001
- 资助金额:
$ 18.15万 - 项目类别:
Synthesis of Anticancer Agents Using Prins Cyclizations
使用 Prins 环化合成抗癌剂
- 批准号:
6400176 - 财政年份:2001
- 资助金额:
$ 18.15万 - 项目类别:
Synthesis of Anticancer Agents Using Prins Cyclizations
使用 Prins 环化合成抗癌剂
- 批准号:
6619600 - 财政年份:2001
- 资助金额:
$ 18.15万 - 项目类别:
Synthesis of anticancer agents using Prins cyclization
使用 Prins 环化合成抗癌药物
- 批准号:
6865345 - 财政年份:1998
- 资助金额:
$ 18.15万 - 项目类别:
相似海外基金
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10448926 - 财政年份:2021
- 资助金额:
$ 18.15万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10491861 - 财政年份:2021
- 资助金额:
$ 18.15万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10675535 - 财政年份:2021
- 资助金额:
$ 18.15万 - 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
- 批准号:
EP/S021868/1 - 财政年份:2019
- 资助金额:
$ 18.15万 - 项目类别:
Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
- 批准号:
529840-2018 - 财政年份:2018
- 资助金额:
$ 18.15万 - 项目类别:
Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403724 - 财政年份:2014
- 资助金额:
$ 18.15万 - 项目类别:
Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403697 - 财政年份:2014
- 资助金额:
$ 18.15万 - 项目类别:
Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
- 批准号:
131690 - 财政年份:2014
- 资助金额:
$ 18.15万 - 项目类别:
Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
- 批准号:
131338 - 财政年份:2013
- 资助金额:
$ 18.15万 - 项目类别:
Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
- 批准号:
429734-2011 - 财政年份:2012
- 资助金额:
$ 18.15万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)